Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dingdang Health Technology Group Ltd. ( (HK:9886) ) just unveiled an update.
Dingdang Health Technology Group Ltd. expects its net loss for 2025 to narrow by more than 80% from the RMB380 million reported in 2024, driven largely by a sharp reduction in impairment charges on goodwill and other intangible assets, as well as ongoing optimization of its urban layout strategy in key first-tier Chinese cities. The company also anticipates achieving an adjusted net profit of at least RMB5 million in 2025, marking a turnaround from an adjusted net loss of RMB57.2 million in 2024, helped by strengthened supply chain capabilities, a more profitable product mix and improved overall operational efficiency, though the figures remain preliminary and unaudited.
More about Dingdang Health Technology Group Ltd.
Dingdang Health Technology Group Ltd. is a Hong Kong-listed healthcare technology company focused on smart pharmacies and online-to-offline pharmaceutical retail services in mainland China. The group concentrates its operations in core first-tier cities such as Beijing, Shanghai and Shenzhen, where it is expanding and densifying its local smart pharmacy networks to enhance operational efficiency and support business growth.
Average Trading Volume: 1,549,738
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.18B
For a thorough assessment of 9886 stock, go to TipRanks’ Stock Analysis page.